pharmacies must stop selling compounded semaglutide after may 2025 As of February 21, 2025, the FDA updated its drug shortage list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A 🚨 FDA Moves to Permanently

Heres how it works: Appetite Suppression GLP-1 medications interact with receptors in the brain to reduce feelings of hunger

Practical tools for managing injection sites Successful long-term semaglutide use requires a system, not just knowledge

Following Eli Lilly's September 2025 price increase for Mounjaro, Wegovy is generally the more affordable option at standard maintenance doses

A doctor's letter is strongly recommended for international travel and essential for some destinations

A New England Journal of Medicine study states that weekly doses of semaglutide, the name of the drug in Wegovy and Ozempic injections, can not only help adolescents ages 12 to 18 with weight reduction but with improving cardiometabolic risk factors that accompany obesity